Stock Earnings

Question 1

What are Leap Therapeutics Inc's key financial statements?

Accepted Answer

According to the latest financial statement (Form-10K), Leap Therapeutics Inc has a total asset of $49, Net loss of $-67

Question 2

What are the key financial ratios for CYPH?

Accepted Answer

Leap Therapeutics Inc's Current ratio is 3.5, has a Net margin is 0, sales per share of $0.

Question 3

How is Leap Therapeutics Inc's revenue broken down by segment or geography?

Accepted Answer

Currently Leap Therapeutics Inc data is not available.

Question 4

Is Leap Therapeutics Inc profitable?

Accepted Answer

no, according to the latest financial statements, Leap Therapeutics Inc has a net loss of $-67

Question 5

Does Leap Therapeutics Inc have any liabilities?

Accepted Answer

yes, Leap Therapeutics Inc has liability of 14

Question 6

How many outstanding shares for Leap Therapeutics Inc?

Accepted Answer

Leap Therapeutics Inc has a total outstanding shares of 38.33

Breakdown	TTM	12/31/2024	12/31/2023	12/31/2022	12/31/2021	12/31/2020
Revenue	0	0	0	0	1	1
Revenue Growth (YoY)	--	--	--	-100%	0%	--
Cost of Revenue	--	--	--	--	--	--
Gross Profit	--	--	--	--	--	--
Selling, General & Admin	9	12	13	11	10	9
Research & Development	37	57	43	44	32	20
Operating Expenses	52	70	57	56	42	30
Other Non Operating Income (Expenses)	0	--	1	2	1	0
Pretax Income	-50	-66	-81	-54	-40	-27
Income Tax Expense	0	0	0	0	0	0
Net Income	-50	-67	-81	-54	-40	-37
Net Income Growth	-22%	-17%	50%	35%	8%	12%
Shares Outstanding (Diluted)	41.44	37.55	20.44	11.32	8.58	5.93
Shares Change (YoY)	1%	84%	81%	32%	45%	163%
EPS (Diluted)	-1.22	-1.81	-3.98	-4.82	-4.73	-6.34
EPS Growth	-22%	-55%	-17%	2%	-25%	-56.99%
Free Cash Flow	-52	-60	-43	-49	-35	-25
Free Cash Flow Per Share	-1.25	-1.59	-2.1	-4.32	-4.07	-4.21
Gross Margin	--	--	--	--	--	--
Operating Margin	0%	0%	0%	0%	-4,100%	-2,800%
Profit Margin	0%	0%	0%	0%	-4,000%	-3,700%
Free Cash Flow Margin	0%	0%	0%	0%	-3,500%	-2,500%
EBITDA	--	-70	-57	-56	-41	-28
EBITDA Margin	--	0%	0%	0%	-4,100%	-2,800%
D&A For EBITDA	--	0	0	0	0	0
EBIT	-52	-70	-57	-56	-41	-28
EBIT Margin	0%	0%	0%	0%	-4,100%	-2,800%
Effective Tax Rate	0%	0%	0%	0%	0%	0%

Leap Therapeutics Inc (CYPH) Price